List of Tables
Table 1. Global Flu Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Flu Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Flu Vaccination Market Competitive Situation by Manufacturers in 2024
Table 4. Global Flu Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Flu Vaccination Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Flu Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Flu Vaccination Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Flu Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Flu Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Flu Vaccination, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Flu Vaccination, Product Type & Application
Table 12. Global Key Manufacturers of Flu Vaccination, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Flu Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Vaccination as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Flu Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Flu Vaccination Sales by Region (2020-2025) & (K Units)
Table 18. Global Flu Vaccination Sales Market Share by Region (2020-2025)
Table 19. Global Flu Vaccination Sales by Region (2026-2031) & (K Units)
Table 20. Global Flu Vaccination Sales Market Share by Region (2026-2031)
Table 21. Global Flu Vaccination Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Flu Vaccination Revenue Market Share by Region (2020-2025)
Table 23. Global Flu Vaccination Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Flu Vaccination Revenue Market Share by Region (2026-2031)
Table 25. North America Flu Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Flu Vaccination Sales by Country (2020-2025) & (K Units)
Table 27. North America Flu Vaccination Sales by Country (2026-2031) & (K Units)
Table 28. North America Flu Vaccination Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Flu Vaccination Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Flu Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Flu Vaccination Sales by Country (2020-2025) & (K Units)
Table 32. Europe Flu Vaccination Sales by Country (2026-2031) & (K Units)
Table 33. Europe Flu Vaccination Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Flu Vaccination Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Flu Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Flu Vaccination Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Flu Vaccination Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Flu Vaccination Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Flu Vaccination Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Flu Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Flu Vaccination Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Flu Vaccination Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Flu Vaccination Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Flu Vaccination Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Flu Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Flu Vaccination Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Flu Vaccination Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Flu Vaccination Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Flu Vaccination Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Flu Vaccination Sales (K Units) by Type (2020-2025)
Table 51. Global Flu Vaccination Sales (K Units) by Type (2026-2031)
Table 52. Global Flu Vaccination Sales Market Share by Type (2020-2025)
Table 53. Global Flu Vaccination Sales Market Share by Type (2026-2031)
Table 54. Global Flu Vaccination Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Flu Vaccination Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Flu Vaccination Revenue Market Share by Type (2020-2025)
Table 57. Global Flu Vaccination Revenue Market Share by Type (2026-2031)
Table 58. Global Flu Vaccination Price (US$/Unit) by Type (2020-2025)
Table 59. Global Flu Vaccination Price (US$/Unit) by Type (2026-2031)
Table 60. Global Flu Vaccination Sales (K Units) by Application (2020-2025)
Table 61. Global Flu Vaccination Sales (K Units) by Application (2026-2031)
Table 62. Global Flu Vaccination Sales Market Share by Application (2020-2025)
Table 63. Global Flu Vaccination Sales Market Share by Application (2026-2031)
Table 64. Global Flu Vaccination Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Flu Vaccination Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Flu Vaccination Revenue Market Share by Application (2020-2025)
Table 67. Global Flu Vaccination Revenue Market Share by Application (2026-2031)
Table 68. Global Flu Vaccination Price (US$/Unit) by Application (2020-2025)
Table 69. Global Flu Vaccination Price (US$/Unit) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi Flu Vaccination Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Company Information
Table 76. CSL Description and Business Overview
Table 77. CSL Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. CSL Flu Vaccination Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GSK Flu Vaccination Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Company Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Viatris Flu Vaccination Product
Table 89. Viatris Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. AstraZeneca Flu Vaccination Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Hualan Bio Company Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hualan Bio Flu Vaccination Product
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Changchun Institute of Biological Company Information
Table 101. Changchun Institute of Biological Description and Business Overview
Table 102. Changchun Institute of Biological Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Changchun Institute of Biological Flu Vaccination Product
Table 104. Changchun Institute of Biological Recent Developments/Updates
Table 105. Sinovac Company Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sinovac Flu Vaccination Product
Table 109. Sinovac Recent Developments/Updates
Table 110. BCHT Company Information
Table 111. BCHT Description and Business Overview
Table 112. BCHT Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. BCHT Flu Vaccination Product
Table 114. BCHT Recent Developments/Updates
Table 115. Jiangsu GDK Company Information
Table 116. Jiangsu GDK Description and Business Overview
Table 117. Jiangsu GDK Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Jiangsu GDK Flu Vaccination Product
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Company Information
Table 121. KM Biologics Description and Business Overview
Table 122. KM Biologics Flu Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. KM Biologics Flu Vaccination Product
Table 124. KM Biologics Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Flu Vaccination Distributors List
Table 128. Flu Vaccination Customers List
Table 129. Flu Vaccination Market Trends
Table 130. Flu Vaccination Market Drivers
Table 131. Flu Vaccination Market Challenges
Table 132. Flu Vaccination Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Flu Vaccination
Figure 2. Global Flu Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Flu Vaccination Market Share by Type: 2024 & 2031
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Flu Vaccination Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Flu Vaccination Market Share by Application: 2024 & 2031
Figure 8. 6 Months to 3 Years
Figure 9. Above 3 Years
Figure 10. Global Flu Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Flu Vaccination Market Size (2020-2031) & (US$ Million)
Figure 12. Global Flu Vaccination Sales (2020-2031) & (K Units)
Figure 13. Global Flu Vaccination Average Price (US$/Unit) & (2020-2031)
Figure 14. Flu Vaccination Report Years Considered
Figure 15. Flu Vaccination Sales Share by Manufacturers in 2024
Figure 16. Global Flu Vaccination Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Flu Vaccination Players: Market Share by Revenue in Flu Vaccination in 2024
Figure 18. Flu Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Flu Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Flu Vaccination Sales Market Share by Country (2020-2031)
Figure 21. North America Flu Vaccination Revenue Market Share by Country (2020-2031)
Figure 22. United States Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Flu Vaccination Sales Market Share by Country (2020-2031)
Figure 25. Europe Flu Vaccination Revenue Market Share by Country (2020-2031)
Figure 26. Germany Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Flu Vaccination Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Flu Vaccination Revenue Market Share by Region (2020-2031)
Figure 33. China Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Flu Vaccination Sales Market Share by Country (2020-2031)
Figure 43. Latin America Flu Vaccination Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Flu Vaccination Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Flu Vaccination Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Flu Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Flu Vaccination by Type (2020-2031)
Figure 53. Global Revenue Market Share of Flu Vaccination by Type (2020-2031)
Figure 54. Global Flu Vaccination Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Flu Vaccination by Application (2020-2031)
Figure 56. Global Revenue Market Share of Flu Vaccination by Application (2020-2031)
Figure 57. Global Flu Vaccination Price (US$/Unit) by Application (2020-2031)
Figure 58. Flu Vaccination Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed